USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING OR PREVENTING ABNORMAL BONE RESORPTION - Patent 1102590

(19)

(11)

EP 1 102 590 A1

(12)

(43)	Date of publication:
	30.05.2001 Bulletin 2001/22

(21)	Application number: 99934993.9

(22)	Date of filing: 30.07.1999

(51)	International Patent Classification (IPC)⁷: A61K 31/5377, A61K 31/675, A61K 31/5375, A61K 31/438, A61K 31/4545, A61K 31/454, A61K 31/451, A61K 31/4035, A61K 31/404, A61K 31/4709, A61K 31/00

(86)	International application number:
	PCT/GB9902/509

(87)	International publication number:
	WO 0007/598 (17.02.2000 Gazette 2000/07)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

04.08.1998 GB 9816897

(71)	Applicant: MERCK SHARP & DOHME LTD.
	HoddesdonHertfordshire EN11 9BU (GB)

(72)	Inventors:
	HARGREAVES, Richard John Harlow,Essex CM20 2QR (GB) RUPNIAK, Nadia Melanie Harlow,Essex CM20 2QR (GB)

(74)	Representative: Hiscock, Ian James
	European Patent Department,Merck & Co., Inc.,Terlings Park,Eastwick Road Harlow,Essex CM20 2QR Harlow,Essex CM20 2QR (GB)

(54)	USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING OR PREVENTING ABNORMAL BONE RESORPTION